Medical robots are a vital component of the global healthcare system. Robot-assisted minimally invasive surgery, with its advantages of less trauma, faster recovery, and fewer complications, has become a significant representative of modern medical productivity. Recently, a remote robot-assisted surgery, spanning over 2,000 kilometers from Chengdu to Lhasa, was successfully completed. This is the world's first single-arm single-port remote robot surgery and another major breakthrough for China in the application of cutting-edge minimally invasive technology.
The Jingfeng single-arm single-port endoscopic surgery robot used in this operation is a high-end medical device fully developed by China. It is currently the only single-arm single-port surgery robot approved for market in China and reaches the international leading level in terms of performance parameters. According to reports, Jingfeng Medical, founded in Shenzhen in 2017, has independently developed and launched a domestically produced endoscopic surgery robot with complete independent intellectual property rights, breaking the technological monopoly of foreign brands. It has achieved a complete breakthrough in core technology and has also made new advancements in key technical parameters. Jingfeng is the first company in China and the second globally to have both multi-port and single-port endoscopic surgery robot products approved for market, and it is currently the only company in the world that has completed both remote multi-port and remote single-port robot-assisted surgeries on humans.
At the 2024 Shenzhen International High-Performance Medical Devices Exhibition and Innovative Pharmaceutical Exhibition held recently, Jingfeng Medical showcased its latest generation of multi-port surgery robot MP2000 and the single-port surgery robot SP1000 Plus, introducing the world's first "three-in-one" surgical solution combining multi-port, single-port, and remote capabilities. This comprehensively demonstrates the technical level and innovative achievements of domestically produced endoscopic surgery robots.
In the "2024 Medical Device Industry Innovation Ecosystem Insight Assessment" released by the National High-Performance Medical Device Innovation Center, Jingfeng Medical was ranked among the top 100 emerging medical device companies in 2024, marking its third consecutive year on the list. In the subfield of surgical robots, it has entered the top ten of the innovation index. Additionally, its single-port endoscopic surgery system was awarded the "2024 Innovative Medical Device Product Star," being the only product developed independently by a Shenzhen company among the ten selected innovative products.
Reporters on the scene learned that the multi-port surgical robot is currently the most widely used endoscopic surgery robot. To date, Jingfeng's multi-port endoscopic surgery robots have been used in more than 5,000 clinical surgeries in over 150 hospitals across 27 provinces in China, widely applied in various complex minimally invasive surgeries with a 100% success rate. The "three-in-one" solution of Jingfeng's single-port and multi-port surgical robots, which share the same doctor control platform and imaging platform, integrates technological innovation, application innovation, and model innovation. The unified control system not only adapts to both multi-port and single-port robots simultaneously but also enables seamless switching between local and remote surgeries. This allows medical experts to conduct precise surgical operations without being physically present, effectively alleviating the issue of uneven distribution of medical resources, maximizing the satisfaction of various clinical needs, and providing more possibilities for the transformation of future medical service models.
Furthermore, Jingfeng Medical has also signed strategic cooperation agreements with several hospitals, including the Shenzhen Hospital of the Chinese Academy of Medical Sciences, Shenzhen Maternal and Child Health Hospital, and Shenzhen Children's Hospital, to jointly promote the advancement of surgical robot technology and the transformation of scientific research achievements. In particular, it is dedicated to promoting the clinical application and innovative development of single-port surgical robots, striving to benefit more patients with the fruits of medical technology innovation.
Customer service 1 
Customer service 2